The regulation of e-scooters in the UK is a growing issue, especially as other major cities ban app-rented models. Madrid, ...

London-listed potash developer Emmerson CFO Jim Wynn has resigned to pursue another opportunity elsewhere, the company revealed on September 27. Wynn, who joined the company in February 2022, will ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

Biomea Fusion has escaped from the full clinical hold imposed by the FDA. | Biomea Fusion has escaped from the full clinical hold imposed by the FDA. After reviewing the data, the regulator has ...

The "Delirium - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering."Delirium - Global Clinical Trials Review, 2024" provides an overview of ...

Dale Whelehan, CEO of 4 Day Week Global, speaks about the reasons why companies might want to consider the change.

Scientists comment on the FDA approving Cobenfy (KarXT) for schizophrenia. Dr Sameer Jauhar, Senior Clinical Lecturer in Affective Disorders and Psychosis, Consultant Psychiatrist, King’s College, ...

India’s artillery modernisation plan is on track, with several contracts expected to be concluded by the end of the current ...

The "Cystic Fibrosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Cystic Fibrosis ...

To enhance its artillery firepower, the Indian Army plans to induct additional regiments of ultra-light howitzers, the K9 ...

On Thursday, the FDA approved Cobenfy, the first medication in decades to fight schizophrenia in a new way FRIDAY, Sept. 27, ...

A meta-analysis reveals gamified digital mental health interventions effectively reduce depression and ADHD in youth, ...